blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2399608

EP2399608 - Immunomodulating nanoparticulate composition for use in inhalation therapy [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.05.2021
Database last updated on 06.07.2024
FormerThe patent has been granted
Status updated on  05.06.2020
FormerGrant of patent is intended
Status updated on  09.12.2019
FormerExamination is in progress
Status updated on  25.11.2016
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Fuchs, Sebastian
Oettingenstrasse 53
80538 München / DE
For all designated states
Coester, Conrad
Frankfurter Strasse 6
36119 Neuhof / DE
For all designated states
Gehlen, Heidrun
Sophie-Charlotte Str. 37b
14169 Berlin / DE
For all designated states
Klier, John
Erlenweg 60
83109 Grosskarolinenfeld / DE
For all designated states
Winter, Gerhard
Antdorfer Str. 18
82377 Penzberg / DE
[2020/28]
Former [2011/52]For all designated states
Fuchs, Sebastian
Oettingenstrasse 53
80538 München / DE
For all designated states
Coester, Conrad
Frankfurter Strasse 6
36119 Neuhof / DE
For all designated states
Gehlen, Heidrun
Sophie-Charlotte Str. 37b
14169 Berlin / DE
For all designated states
Klier, John
Erlenweg 60
83109 Grosskarolinenfeld / DE
For all designated states
Winter, Gerhard
Antdorfer Strasse 18
82377 Penzberg / DE
Inventor(s)01 / see applicant
...
 [2011/52]
Representative(s)(deleted)
[2011/52]
Application number, filing date11001858.707.03.2011
[2011/52]
Priority number, dateEP2010000226605.03.2010         Original published format: EP 10002266
[2012/05]
Former [2011/52]EP2010000226603.05.2010
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2399608
Date:28.12.2011
Language:EN
[2011/52]
Type: B1 Patent specification 
No.:EP2399608
Date:08.07.2020
Language:EN
[2020/28]
Search report(s)(Supplementary) European search report - dispatched on:EP28.11.2011
ClassificationIPC:A61K47/69, A61K9/00, A61P11/06
[2019/51]
CPC:
A61K47/6929 (EP,US); A61K9/0078 (EP,US); A61P29/00 (EP);
A61P37/02 (EP); A61P37/08 (EP)
Former IPC [2011/52]A61K47/48, A61K9/00, A61K9/51
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/28]
Former [2011/52]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Immunmodulierende Nanopartikelzusammensetzung zur Verwendung in einer Inhalationstherapie[2020/24]
English:Immunomodulating nanoparticulate composition for use in inhalation therapy[2011/52]
French:Composition à nanoparticules immunomodulatrices à utiliser dans une thérapie d'inhalation[2011/52]
Former [2011/52]Immunmodulierende Nanoteilchenzusammensetzung zur Verwendung in einer Inhalationstherapie
Examination procedure26.06.2012Examination requested  [2012/32]
02.07.2012Amendment by applicant (claims and/or description)
09.08.2013Despatch of a communication from the examining division (Time limit: M06)
10.02.2014Reply to a communication from the examining division
26.01.2015Despatch of a communication from the examining division (Time limit: M06)
10.11.2015Reply to a communication from the examining division
13.05.2016Despatch of a communication from the examining division (Time limit: M06)
22.11.2016Reply to a communication from the examining division
25.09.2017Despatch of a communication from the examining division (Time limit: M02)
15.01.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.03.2018Reply to a communication from the examining division
10.12.2019Communication of intention to grant the patent
30.03.2020Fee for grant paid
30.03.2020Fee for publishing/printing paid
19.04.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.08.2013
Opposition(s)09.04.2021No opposition filed within time limit [2021/24]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
17.03.2018Request for further processing filed
17.03.2018Full payment received (date of receipt of payment)
Request granted
11.04.2018Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
11.11.2015Request for further processing filed
11.11.2015Full payment received (date of receipt of payment)
Request granted
19.11.2015Decision despatched
Fees paidRenewal fee
28.03.2013Renewal fee patent year 03
28.03.2014Renewal fee patent year 04
30.03.2015Renewal fee patent year 05
31.03.2016Renewal fee patent year 06
31.03.2017Renewal fee patent year 07
29.03.2018Renewal fee patent year 08
19.09.2019Renewal fee patent year 09
31.03.2020Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.03.201909   M06   Fee paid on   19.09.2019
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.03.2011
AL08.07.2020
AT08.07.2020
CY08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
MC08.07.2020
MK08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
LU07.03.2021
[2024/22]
Former [2023/27]HU07.03.2011
AL08.07.2020
AT08.07.2020
CY08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
MC08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
LU07.03.2021
Former [2023/24]AL08.07.2020
AT08.07.2020
CY08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
MC08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
LU07.03.2021
Former [2022/09]AL08.07.2020
AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
MC08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
LU07.03.2021
Former [2021/45]AL08.07.2020
AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
MC08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/36]AL08.07.2020
AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/28]AL08.07.2020
AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/25]AL08.07.2020
AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/23]AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
SM08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/22]AT08.07.2020
CZ08.07.2020
DK08.07.2020
EE08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/20]AT08.07.2020
DK08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
IT08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RS08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/17]AT08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
LT08.07.2020
LV08.07.2020
NL08.07.2020
PL08.07.2020
RS08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/10]AT08.07.2020
ES08.07.2020
FI08.07.2020
HR08.07.2020
LT08.07.2020
LV08.07.2020
PL08.07.2020
RS08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
IS08.11.2020
PT09.11.2020
Former [2021/09]AT08.07.2020
ES08.07.2020
FI08.07.2020
LT08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
GR09.10.2020
PT09.11.2020
Former [2021/08]ES08.07.2020
FI08.07.2020
LT08.07.2020
SE08.07.2020
BG08.10.2020
NO08.10.2020
PT09.11.2020
Former [2021/07]FI08.07.2020
LT08.07.2020
NO08.10.2020
Documents cited:Search[Y]  - FONSECA D E ET AL, "Use of CpG oligonucleotides in treatment of asthma and allergic disease", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 61, no. 3, doi:10.1016/J.ADDR.2008.12.007, ISSN 0169-409X, (20090328), pages 256 - 262, (20090109), XP025972631 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.addr.2008.12.007
 [Y]  - KLAUS ZWIOREK ET AL, "Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG Oligonucleotides", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, (20071003), vol. 25, no. 3, ISSN 1573-904X, pages 551 - 562, XP019579465 [Y] 1-15 * abstract *
 [Y]  - BRZOSKA M ET AL, "Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20040528), vol. 318, no. 2, doi:10.1016/J.BBRC.2004.04.067, ISSN 0006-291X, pages 562 - 570, XP004505417 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2004.04.067
 [T]  - KLIER JOHN ET AL, Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles., VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 15 NOV 2011 LNKD- PUBMED:21831455, VOL. 144, NR. 1-2, PAGE(S) 79 - 87, (20111115), ISSN 1873-2534, XP055012488

DOI:   http://dx.doi.org/10.1016/j.vetimm.2011.07.009
ExaminationWO2007068747
    - WANG G ET AL, Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles, EXPERT OPINION ON DRUG DELIVERY 200805 GB, VOL. 5, NR. 5, PAGE(S) 499 - 515, (200805), ISSN 1742-5247
    - KLIER J ET AL, Nanoparticulate CpG Immunotherapy in RAO- Affected Horses: Phase I and IIa Study, JOURNAL OF VETERINARY INTERNAL MEDICINE, VOL. 29, NR. 1, PAGE(S) 286-293, (201501), ISSN 0891-6640(print)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.